Stock screener
All disclosures →
EDGAR →
VRTX
Conviction 91HealthcareScan · Wed, Sep 23, 2026Bullish harami
Vertex Pharmaceuticals Inc / Ma (VRTX) closed at $516.08 (+0.21%) on Sep 23, 2026. Its latest daily candle is a bullish harami. Price is above its 50-day and above its 200-day moving average. RSI(14) 47, RS Rating 83, -7.5% from its 52-week high, +14.1% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.
VRTX$516.08+0.21%
ResistanceSupportVol 14Insider sellCongress buyCongress sell2
Vol MA14 1.09M
Jun 25Jul 14Jul 31Aug 18Sep 4Sep 23
Price516.08
Change+0.21%
Gap+0.11%
Rel volume1.95×
Avg volume1.08M
Avg $ vol567.86M
SMA 20529.17
SMA 50512.59
SMA 200471.09
Price vs 50+0.68%
Price vs 200+9.55%
MA stackbullish
50/200 cross—
Supertrenddown · 542.31
RSI (14)47
MACD hist-3.30
MACD cross—
Stoch %K / %D25 / 22
ADX (14)20
+DI / −DI20 / 21
RSI divergenceBearish
MACD divergenceBullish
ATR %2.46%
ADR %2.04%
52w high557.96
52w low376.62
From 52w high-7.51%
Above 52w low+37.03%
New 52w highNo
SqueezeOff
Bollinger width12.66%
%B0.30
Donchian pos25.44%
Donchian high560.25
Donchian low501.01
AVWAP (52w high)520.18
vs AVWAP high-0.79%
AVWAP (52w low)460.09
vs AVWAP low+12.17%
OBV trendFlat
Chaikin MF (20)-0.11
Today vs 20d1.95×
Avg vol (14d)1.09M
Avg vol (20d)1.08M
Avg $ vol (20d)567.86M
Market cap130.81B
RS Rating83 / 99
RS 3m (vs SPY)+3.89%
RS 6m (vs SPY)-2.51%
RS line new highNo
Trend template8/8
Technical rank67.5
1 week+0.55%
1 month-5.75%
3 months+8.60%
6 months+15.04%
1 year+34.70%
YTD+14.14%
P/E33.09
P/B6.46
P/S10.90
P/FCF40.96
EPS15.32
Div yield—
ROE19.52%
ROA14.42%
Debt/Eq0.01
Current3.19
EV/EBITDA28.47
Gross margin—
Net margin32.94%
Rev growth8.90%
EPS growth838.09%
Price target576.57
Target upside11.72%
Analyst ratingBuy
Institutional105.77%
Ent. value124.77B
Revenue3.33B
Net income1.1B
Gross profit—
Free cash flow3.19B
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out253.81M
Employees6.4K
ListedWed, Jul 31, 1991
Free float253.88M
Float %99.8%
Short interest4.66M
Days to cover4.5d
Short volume64.4%
Squeeze score57 / 100
Next earnings—
EPS forecast—
Last EPS vs est$4.20 vs $4.15
Last surprise+1.2% beat
Setup gradeA+
Conviction91 / 100
Pattern quality—
Tech rank67.5 / 100
Group rank68 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish harami
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in VRTX · 10 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
David J. Taylor house · R · OH · traded 2026-08-26 | Sell | $1K–$15K | 2026-08-26 | 2026-09-05 | |
 Thomas H Tuberville senate · traded 2024-05-03 | Sell | $1K–$15K | 2024-05-03 | 2026-08-05 | |
 Alan Armstrong senate · R · OK · traded 2026-03-27 | Buy | $1K–$15K | 2026-03-27 | 2026-07-21 | |
David J. Taylor house · R · OH · traded 2025-08-07 | Buy | $1K–$15K | 2025-08-07 | 2025-09-02 | |
 Lisa McClain house · R · MI · traded 2024-12-11 | Buy | $1K–$15K | 2024-12-11 | 2025-08-13 | |
Lisa McClain house · R · MI · traded 2025-06-11 | Sell | $1K–$15K | 2025-06-11 | 2025-08-13 | |
Lisa McClain house · R · MI · traded 2025-06-10 | Sell | $1K–$15K | 2025-06-10 | 2025-08-13 | |
 Jefferson Shreve house · R · IN · traded 2025-05-12 | Sell | $15K–$50K | 2025-05-12 | 2025-06-22 | |
 Byron Donalds house · R · FL · traded 2025-03-20 | Sell | $1K–$15K | 2025-03-20 | 2025-04-14 | |
Jefferson Shreve house · R · IN · traded 2025-03-13 | Buy | $15K–$50K | 2025-03-13 | 2025-04-11 |
Insider activity
SEC Form 4 transactions in VRTX · open-market 6 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Ambrose Kristen SVP & Chief Accounting Officer · Common Stock · 2026-08-28 | Grant | 5K | — | 2026-08-28 | 2026-09-01 |
SACHS BRUCE I Director · Common Stock · 2026-08-27 | Gift | 6K | — | 2026-08-27 | 2026-08-31 |
Garber Alan M Director · Deferred Stock Units · 2026-07-15 | Grant | 31.56 | $15K | 2026-07-15 | 2026-07-17 |
SACHS BRUCE I Director · Deferred Stock Units · 2026-07-15 | Grant | 99.941 | $47K | 2026-07-15 | 2026-07-17 |
McKechnie Duncan EVP, Chief Commercial Officer · Common Stock · 2026-07-02 | Sell | 1.54K | $800K | 2026-07-02 | 2026-07-07 |
Tatsis Ourania EVP, Chief Reg. & Quality Off. · Common Stock · 2026-07-02 | Sell | 1.5K | $787K | 2026-07-02 | 2026-07-07 |
Bozic Carmen EVP and CMO · Common Stock · 2026-06-26 | Sell | 596 | $288K | 2026-06-26 | 2026-06-30 |
Bozic Carmen EVP and CMO · Common Stock · 2026-06-15 | Sell | 4.06K | $1.8M | 2026-06-15 | 2026-06-17 |
Bozic Carmen EVP and CMO · Common Stock · 2026-06-05 | Sell | 1.75K | $785K | 2026-06-05 | 2026-06-09 |
Liu Joy EVP and Chief Legal Officer · Common Stock · 2026-06-01 | Sell | 828 | $364K | 2026-06-01 | 2026-06-03 |
SEC filings
EDGAR filings in VRTX · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.